Predicting steroid responsiveness using airway smooth muscle in COPD: a HISTORIC study
- PMID: 37474151
- DOI: 10.1183/13993003.00956-2023
Predicting steroid responsiveness using airway smooth muscle in COPD: a HISTORIC study
Conflict of interest statement
Conflict of interest: D.D. Sin has received a stipend for giving talks on COPD from AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim. J.M. Leung has no potential conflicts of interest to disclose.
Comment on
-
Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial.Eur Respir J. 2023 Jul 20;62(1):2300218. doi: 10.1183/13993003.00218-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37385657 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical